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1684-1182/Copyright ª 2015, TaiwanAbstract Background/Purposes: Early diagnosis of dengue virus (DENV) infection to monitor
the potential progression to hemorrhagic fever can influence the timely management of
dengue-associated severe illness. Nonstructural protein 1 (NS1) antigen detection in acute
serum specimens has been widely accepted as an early diagnostic assay for dengue infection;
however, lower sensitivity of the NS1 antigen-capture enzyme-linked immunosorbent assay
(Ag-ELISA) in secondary dengue viral infection has been reported.
Methods: In this study, we developed two forms of Ag-ELISA capable of detecting E-Ag contain-
ing virion and virus-like particles, and secreted NS1 (sNS1) antigens, respectively. The tempo-
ral kinetics of viral RNA, sNS1, and E-Ag were evaluated based on the in vitro infection
experiment. Meanwhile, a panel of 62 DENV-2 infected patients’ sera was tested.
Results: The sensitivity was 3.042 ng/mL and 3.840 ng/mL for sNS1 and E, respectively. The
temporal kinetics of the appearance of viral RNA, E, NS1, and infectious virus in virus-
infected tissue culture media suggested that viral RNAs and NS1 antigens could be detected
earlier than E-Ag and infectious virus. Furthermore, a panel of 62 sera from patients infected
by DENV Serotype 2 was tested. Treating clinical specimens with the dissociation buffer
increased the detectable level of E from 13% to 92% and NS1 antigens from 40% to 85%.nstitute of Microbiology and Public Health, College of Veterinary Medicine, National Chung-Hsing
.tw (D.-Y. Chao).
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j.jmii.2015.05.008Conclusion: Inclusion of a low-pH glycine buffer treatment step in the commercially available
Ag-ELISA is crucial for clinical diagnosis and E-containing viral particles could be a valuable
target for acute DENV diagnosis, similar to NS1 detection.
Copyright ª 2015, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Dengue virus (DENV) serotypes 1e4 (DENV-1, DENV-2,
DENV-3, and DENV-4) are the most widespread mosquito-
borne viral pathogens worldwide in humans, accounting
for >390 million infections/y.1 Currently, there is no
approved human vaccine or antiviral treatment available
for DENV infection. Thus, an accurate and early diagnosis
of DENV infection is essential for implementing the early
clinical management critical to reduce the morbidity and
mortality of dengue hemorrhagic fever and dengue shock
syndrome.
DENV belongs to the genus Flavivirus of the family Fla-
viviridae. It is an enveloped virus containing single-
stranded, positive-sense RNA, which encodes three struc-
tural proteins: capsid (C), premembrane (prM), and enve-
lope (E), and seven nonstructural (NS) proteins: NS1, NS2A,
NS2B, NS3, NS4A, NS4B, and NS5.2 Viral RNA synthesis can
be detected 3e6 hours after infection, and progeny virions
are released from infected mammalian cells starting
approximately 10e12 hours postinfection.3 Maximal extra-
cellular virus titers are not usually observed until approxi-
mately 24 hours postinfection. In DENV-infected mosquitos4
or mammalian cell culture, a soluble hexameric form of NS1
protein is secreted into the cultured supernatant in a
glycosylation-dependent fashion and in free-form associa-
tion with virion particles,5,6 and the levels of secreted NS1
(sNS1) correlate with infectious virus titers.7 The circu-
lating sNS1 during the acute phase of the disease is higher
in patients’ serum specimens experiencing primary rather
than secondary infection.8,9
Recent studies suggested the lower sensitivity of the NS1
antigen-capture enzyme-linked immunosorbent assay (NS1-
ELISA) in secondary infection compared with primary
infection is due to the early formation of NS1-antibody
complex impending the plate-bound capturing and/or
detecting antibodies to access antibody-targeted epi-
tope(s).10,11 In this study, an optimized NS1- and E-specific
murine monoclonal antibody (mAb) based NS1- and E-ELISA,
respectively were developed to focus on three specific
aims: (1) to detect and quantify the levels of DENV E and
sNS1 in virus-infected tissue culture fluids, and utilize this
assay to examine an extensive number of well-
characterized dengue patient serum samples; (2) to inves-
tigate whether E-antibody complexes reduced the sensi-
tivity of E-ELISA similar to the phenomena observed for
NS1-ELISA in human serum as suggested in the previous
study12; and (3) to evaluate if serum specimens pretreated
with dissociation buffer improved the sensitivity of NS1-
and E-ELISA detection in DENV-infected patient serum
specimens.en W-F, et al., Improving dengue v
t, Journal of Microbiology, ImMethods
Virus, cells, and antibodies
The DENV-2 virus (strain 16681) used in this study was prop-
agated in Aedes albopictus clone C6/36 cells obtained from
the American Type Culture Collection (ATCC, Manassas, VA,
USA) and grown at 28C in Dulbecco’s minimum essential
medium (DMEM) supplemented with 10% heat inactivated
fetal bovine serum (FBS) andnonessential amino acids (Gibco
BRL, Grand Island, NY, USA). Vero cells for viral infection and
plaque assay and COS-1 cells (ATCC CRL 1650) for E produc-
tion were grown at 37C with 5% CO2 in DMEM supplemented
with 10% heat-inactivated FBS. Virus stocks were used to
infect 80% confluent Vero cell monolayers in DMEM medium
supplemented with 2% FBS and incubated at 37C until the
day designated, at which point the supernatants and cell
monolayers were harvested.
Flavivirus group-cross reactive, E-specific DB42-3, and
NS1-specific DB20-6 monoclonal antibodies (mAbs) were
generated and purified as previously described.13,14 These
two mAbs were chosen based upon their strengths of
binding to E and NS1 and their cross-reactivity with other
flaviviruses. Mouse hyperimmune ascitic fluid (MHIAF)
against DENV-2 strain New Guinea C was provided by the US
Centers for Disease Control and Prevention (US-CDC).
Polyclonal rabbit anti-DENV-2 E and NS1 were generated by
intramuscular injection of E or NS1 expressed DNA plasmids
as described in the plasmid construction section below and
were kindly provided by one of the authors, Dr. GJ Chang’s
laboratory at the US-CDC.Plasmid construction, protein expression, and
purification
The pcDNA3-based vaccine plasmids encoding the prM/E or
NS1 genes of the DENV-2 strain 16681, named pCBD2E and
pCBD2NS1, respectively, were constructed as described
previously.15,16 The prM/E containing virus-like particles
(VLPs) andNS1were expressed by COS-1 cells electroporated
with pCBD2E and pCBD2NS1 using the protocol described
previously.17,18 Supernatants were harvested and clarified
from media of electroporated cells 4e5 days post-
transformation. Media containing VLPs were concentrated
by polyethylene glycol precipitation (10% PEG), and media
containing NS1 were concentrated by ultrafiltration using a
10-kD pore size centricon (Millipore, Billerica, MA, USA);
finally, concentrated VLPs and NS1 antigens were further
purified using Cellufine Sulfate columns (Chisso, Tokyo,
Japan) as previously suggested.19 Columnswerewashedwithiral antigens detection in dengue patient serum specimens using a
munology and Infection (2015), http://dx.doi.org/10.1016/
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NaCl, pH 7.5) and then 0.4M and 0.6M NaCl in adsorption
buffer were used to elute NS1 and VLPs, respectively. The
purity of DENV-2 VLPs and NS1 was determined using western
blot and ELISA using MHIAF. Protein concentration was
measured using the Bradford protein assay (Bio-Rad, Hercu-
les, CA, USA).
E- and NS1-specific ELISA
Microtitration plates (Nunc Maxisorp; Nunclon Nunc, Ros-
kilde, Denmark) were coated overnight at 4C with 50 mL/
well of the E- or NS1-specific mAb at a concentration of
27 ng/mL in phosphate buffered saline (PBS). Wells were
washed with PBS-Tween buffer (PBS, 0.05% Tween-20) and
blocked with 200 mL/well of blocking buffer (PBS, 0.05%
Tween-20, 3% skim-milk) at room temperature for 2 hours.
Samples, VLPs, or NS1 diluted serially were added to wells
(50 mL/well) and incubated for 2 hours at room temperature.
The wells were washed again and incubated for 1 hour at
37C with 50 mL/well of anti-E or anti-NS1 rabbit antiserum
(diluted 1:500 in blocking buffer). The wells were washed
again and incubated for 1 hour at 37C with 50 mL/well of
peroxidase-conjugated goat anti-rabbit antiserum (Jackson
Immunoresearch, West Grove, PA, USA) diluted 1:5000 in
blocking buffer. After three further washes, each well
received 50 mL of a freshly prepared 3,30,5,50-tetrame-
thylbenzidine solution (TMB; Kirkegaard & Perry Labora-
tories, Gaithersburg, MD, USA). The color reaction was
stopped after 10 minutes with 50 mL/well of 2N sulfuric acid,
and optical density (OD) was measured at 450 nm. Bovine
serum albumin (BSA, 1%) and mock infection culture super-
natant were included in each plate as negative controls for
constructing E- or NS1-specific standard curves and for the
in vitro reconstitutive assay. Five normal healthy human
serum samples obtained from local residents were used as
the normal serum to determine the background cutoff ELISA
OD valuewhen the assaywas used to determine the presence
of E or NS1 in dengue patient serum specimens. Absorbance
values were corrected by subtracting the mean OD values of
the negative controls. A sample is considered positive if its
corrected OD value is two times greater than or equal to the
average OD of the negative control (P/N ratio 2).
Quantification of free and antibody-bound
E and NS1
To determine the temporal kinetics of E and NS1 protein
expression in virus infected cell cultures, Vero cells were
plated in six well plates at a cell density of 6  105 cells/
well with 2 mL of DMEM growth medium. Cells at 80%
confluence were infected with DENV-2 strain 16681 in a
given multiplicity of infection (MOI). Cell supernatants from
infected and uninfected cells were collected at designated
times postinfection, briefly centrifuged, and stored at
70C prior to analysis. The virus culture supernatants
harvested at different time points were diluted in the
washing buffer; the human specimens were initially per-
formed at 1:10 dilution, and threefold serial dilutions were
carried out and tested. The concentration of E and NS1
present was extrapolated based on the OD450 responsePlease cite this article in press as: Shen W-F, et al., Improving dengue v
low pH glycine buffer treatment, Journal of Microbiology, Im
j.jmii.2015.05.008curve of purified E and NS1 after subtracting the OD450 of
the noninfected cell supernatants.
The immune complexes formed in vitro were performed
via incubation of purified VLP and sNS1 with designated
dilutions of DENV-2 MHIAF at 4C overnight. Antibody
complexes formed in vitro were initially diluted 1:2 in
dissociation buffer [1.5M glycine (pH 2.8) in PBS with 1%
BSA]. Immune complexes were dissociated for 1 hour at
37C, and the reaction was stopped by the addition of one
volume of neutralization buffer [1.5M Tris-HCl (pH 9.7)].
Finally, 2.5 volumes of PBS were added to achieve an end
dilution of 1:10 for the sample. The same protocol was
applied to release DENV-2 E and NS1 from immune com-
plexes in dengue patients’ plasma samples for detection.
All samples were assayed in duplicate (sNS1 and E) in a
blinded fashion and were quantified on the linear portion of
the standard curves.
Human serum panel
A total of 62 serum samples from DENV-2 infected patients
during an epidemic in Taiwan between 2002 and 2003 were
used in this study. Diagnosis of DENV infection was based on
immunoglobulin (Ig) M antibody-capture ELISA, reverse-
transcriptase polymerase chain reaction (RT-PCR), or virus
isolation in cell cultures as previously described.20,21 These
serum specimens were collected between Day 1 and Day 13
after onset of fever.
Ethics statement
The use of samples was approved by the National Taiwan
University Institutional Review Board (NTUH-REC No.
200903086R), Kaohsiung Veteran General Hospital Review
Board (VGHK98-CT8-10), and Kaohsiung Yuang’s General
Hospital (IRB #20090430B). Written informed consent was
obtained from all participants and all samples were coded
for anonymity. All of the coauthors and their affiliations in
this study followed the protocol stated in Institutional re-
view board (IRB) accepted from the other institutes.
Statistical analysis
The Student t test was used for comparisons between
normally distributed continuous variables and the Mann-
Whitney U test was used for comparisons between contin-
uous variables not normally distributed. c2 analysis was
used for comparisons among proportional data. The
Graphpad prism 4.0 software package (GraphPad Software
Inc., La Jolla, CA, USA) was used for all statistical analyses.
Results
Sensitivity of E- and NS1-ELISA
The results of the western blotting of E and NS1 are shown
in Figure 1A and B, respectively, and the total proteins of
the eluents were further measured as shown in Figure 1C. It
was consistent with the result from the western blotting,
which suggested that the Cellufine Sulfate columnsiral antigens detection in dengue patient serum specimens using a
munology and Infection (2015), http://dx.doi.org/10.1016/
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the results, equal amounts of total proteins from each
preparation were applied to E- and NS1-ELISA and the OD450
reading in the eluents increased as shown in Figure 1D. To
establish the sensitive Ag-ELISA for measuring levels of E
and NS1 during dengue viral infection, purified DENV-2 NS1
and E containing VLPs with serial dilutions were used to
construct the OD450 response curve. As shown in Figure 1E,
the minimum concentration of NS1 and E that could
generate P/N 2 by this assay was estimated to be at
3.056 ng/mL and 2.978 ng/mL, respectively.Figure 1. Characterization of native secreted nonstructural pr
(DENV)-2 protein standard. Tissue culture medium from cells e
concentrated and then applied to Cellufine Sulfate columns. Equal
before column purification (BC), flow-through buffer (F), and elut
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). T
onto nitrocellulose membranes and immunostained with DENV-2 m
Optical density (OD) readings were shown from equal volume (50 m
using (C) Bradford total protein assay and (D) equal concentrations
ELISAs. Wash buffer was used as negative control (NC). Serial dilutio
reactivity of monoclonal antibodies DB42-3 and DB20-6 (in concent
decided to be a sample OD reading two times greater than the ave
Graphs represent the results from two independent experiments a
Please cite this article in press as: Shen W-F, et al., Improving dengue v
low pH glycine buffer treatment, Journal of Microbiology, Im
j.jmii.2015.05.008Temporal kinetics of appearance of viral RNA, E,
NS1, and infectious virus in virus-infected tissue
culture media
To test whether our NS1- and E-ELISAs can reliably detect
sNS1 and secreted E (either in the form of virions or VLPs)
from DENV-2 infected mammalian cells, Vero cells were
infected with different MOI and harvested culture super-
natants at different time points postinfection to assay the
presence of NS1, E, viral RNA, and infectious virus. NS1otein 1 (sNS1) and virus-like particles (VLP) of dengue virus
lectroporated with the E- and NS1-encoding plasmids were
volumes (10 mL of each fraction) of VLP and sNS1 concentrates
ed antigens (AC) were separated using 10% denaturing sodium
he gels of purified (A) VLP and (B) sNS1 were electroblotted
ouse hyperimmune ascitic fluid (MHIAF) as shown in and (B).
L of each) of BC, F, and AC of purified VLP and sNS1 measured
(100 ng of total protein) carried out with E- or sNS1-Ag capture
ns of purified sNS1 and VLP antigens (E) were tested against the
ration of 27 ng/mL). The cutoff value for positive samples was
rage OD of the negative control (referred to as P/N ratio  2).
nd each was performed with duplicate samples.
iral antigens detection in dengue patient serum specimens using a
munology and Infection (2015), http://dx.doi.org/10.1016/
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hours postinfection at MOI of 0.01, 0.1, and 1, respectively.
NS1 drastically accumulated at the first 20 hours of infec-
tion and gradually increased until 120 hours postinfection,
the last collection point (Figure 2A). The detection of E was
delayed and could be detected at 36 hours, 24 hours, and
16 hours postinfection at an MOI of 0.01, 0.1, and 1,
respectively (Figure 2B). The pattern of detecting E and
detecting viral RNA or infectious viruses was similar. Viral
RNAs and NS1 antigens were detected a few hours earlier
than E. Viral RNA could be detected at 22 hours, 16 hours,
and 6 hours postinfection at an MOI of 0.01, 0.1, and 1,
respectively. However, the viral RNA copy numbers peaked
at 4 days, 3 days, and 2 days postinfection at an MOI of
0.01, 0.1, and 1, respectively, before beginning to decline
(Figure 2C). Consistently, the earliest time points to detect
the infectious virus titer were similar to E detection
(Figure 2D).
Antibody-antigen complexes influencing E and NS1
detection
Previous studies suggest that decreased detection of NS1
antigens in plasma is correlated with the production of anti-
NS1 IgMor IgGantibodies.12,22 Basedon these observations, it
was speculated that the presence of anti-E antibodies would
similarly decrease the sensitivity of E-ELISA in detecting
levels of E-Ag in plasma. The constant concentration (256 ng)Figure 2. Detection of secreted nonstructural protein 1 (sNS1),
(DENV)-2 infected Vero cells. Vero cells were infected with DENV-2
1. Culture supernatants from infected or uninfected cells were colle
sNS1-antigen-capture enzyme-linked immunosorbent assay (Ag-EL
after comparison with a standard curve derived on the same ELISA
standard antigens. The graph shows the average results of three ind
infectious virus in culture fluids was measured using (C) real-time
the standard plaque assay method. The standard deviations for sN
time point are indicated.
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j.jmii.2015.05.008of purified VLP and NS1 was premixed with various dilutions
of MHIAF to test if preformed E and NS1 antibody-complex
reduced the sensitivities of E- and NS1-ELISA. As expected,
E-antibody immune complexes markedly reduced the sensi-
tivity of the E-ELISA in a dose-dependent relationship
(Figure 3A). Similar results were observed for NS1-antibody
complexes (Figure 3B). Then, the E- and NS1-antibody com-
plexes were treated with dissociation buffer or neutral
buffer and Ag-ELISA performed after respective treatment.
Detection of E was enhanced when immune complexes were
treated with low pH dissociation buffer relative to those
treated at neutral pH at 37C for 1 hour as shown by dot blot
assay (Figure 3C and D).
Dengue patient sera using Ag-ELISA with or without
dissociation buffer treatment
A panel of 62 DENV-2 infected patient serum specimens was
examined using our NS1- and E-ELISA. Specimens were
assayed for the presence of NS1 and E without pretreating
serum with the dissociation buffer. NS1 antigen was
detected from Day 1 to Day 10 after onset of fever, peaking
during Day 4 with 80% of the samples detected positive
(Figure 4A). A significant decline in circulating NS1 was
observed after Day 7, although the level of NS1 was still
above the detection limit of our NS1-ELISA. Conversely, E
was detected in our serum collection only during Days 4e9
and the detectable E was much lower than that of NS1 inE-antigen, RNA copies, and infectious virus from dengue virus
strain 16681 at a multiplicity of infection (MOI) of 0.01, 0.1, and
cted at designated times postinfection, and measured using (A)
ISA) and (B) E-Ag-ELISA. The concentrations were calculated
plate using the purified virus-like particles (VLP) and sNS1 as
ependent experiments performed in duplicate. In parallel, the
reverse-transcriptase polymer chain reaction (RT-PCR) and (D)
S1/E-Ag concentrations and the infectious virus titers at each
iral antigens detection in dengue patient serum specimens using a
munology and Infection (2015), http://dx.doi.org/10.1016/
Figure 3. Formation and dissociation of antigen-antibody immune complexes. The immune complexes were formed via incu-
bation of purified virus-like particles (VLP) and secreted nonstructural protein 1 (sNS1) with designated dilutions of dengue virus
(DENV)-2 mouse hyperimmune ascitic fluid (MHIAF) at 4C overnight and detected using (A) E-antigen-capture enzyme-linked
immunosorbent assay (Ag-ELISA) or (B) sNS1-Ag-ELISA. Antibody complexes formed in vitro were initially diluted 1:2 in dissocia-
tion buffer [1.5M glycine (pH 2.8) in PBS with 1% bovine serum albumin (BSA)]. Immune complexes were dissociated for 1 hour at
37C, and the reaction was stopped by the addition of 1 volume of neutralization buffer [1.5M Tris-HCl (pH 9.7)]. Finally, 2.5
volumes of PBS were added to achieve an end dilution of 1:10 for the sample. Equal amounts were added to nitrocellulose
membrane and detected using (C) dot blot assay, in which DB42-3 was used for detection as the immune complexes were formed
using anti-envelope rabbit serum. The densities of the antigens detected were quantified using Bio-1D software (SIM International
Group, Newark, Delaware, USA) and the concentrations of each density were derived from the density based on using the VLP only
(256 ng) as standard. (D) The percentages of E-Ag detected by DB42-3 were calculated using the following formula: 100*(ng of
immune complexes/ng of VLP only). Error bars indicate standard deviations. Except NC and PC, each blot was 256 ng/mL.
NC Z negative control, blocking buffer; PC Z positive control, DENV-2 virus.
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+ MODELcirculation. The free (antibody unbound) E was never
detected beyond Day 9 from our serum collection.
Next, the entire serum collection was pretreated with
dissociation buffer and the post-treated specimens were
subjected to E- and NS1-ELISA. Treating specimens with the
dissociation buffer increased the detectable level of E in
serum samples collected between Day 1 and Day 13
(Figure 4B), and the antigen levels detected also increased
approximately threefold. Likewise, the level of detectable
NS1 increased significantly, and the range of detection was
extended to Day 13. The detection rate of NS1 antigens
increased from 40% to 85% before and after dissociation
buffer treatment, respectively. Similarly, E-Ag detection
rate also increased from 13% to 92%.Discussion
E- and NS1-specific Ag-ELISAs were developed using flavi-
virus group-cross reactive mAbs as the detectors,Please cite this article in press as: Shen W-F, et al., Improving dengue v
low pH glycine buffer treatment, Journal of Microbiology, Im
j.jmii.2015.05.008respectively, in this study. Using the positive OD450/nega-
tive OD450 2 as the cutoff P/N ratio, as low as 2.978 ng/mL
and 3.056 ng/mL of the purified E containing VLPs and NS1
proteins, respectively, were detected. This E-ELISA could
detect E from dengue-infected tissue culture supernatants
and from acute dengue patient serum specimens, similar to
NS1-ELISA. In addition to NS1 and viral RNA detection, the
correlation between E, NS1, and viral RNA in dengue pa-
tient serum specimens should provide further insights for
the improvement of dengue diagnosis in the future. Using
NS1- and E-specific mAbs to recognize flavivirus group cross-
reactive epitopes, this assay may not only be suitable for
DENV-2 detection but could potentially be expanded for
detection of the other three serotypes of DENV.
In this study, the ex vivo tissue culture investigation into
the kinetics related to viral replication suggests that NS1
viral protein is synthesized and released first, followed by
RNA replication, and virion assembly and release. These
findings contradict those of the previous study of West Nile
virus, which indicated that the release of NS1 into theiral antigens detection in dengue patient serum specimens using a
munology and Infection (2015), http://dx.doi.org/10.1016/
Figure 4. Comparison of detection of secreted nonstructural
protein 1 (sNS1) and E-antigen levels in dengue virus (DENV)-2
patient plasma samples with and without dissociation of im-
mune complexes. A panel of 62 serum samples collected from
DENV-2-infected patients at different time points after fever
onset during an epidemic in Taiwan between 2002 and 2003
was tested for the presence of E and sNS1 antigen via our
antigen-capture enzyme-linked immunosorbent assay (Ag-
ELISA). A set of 18 serum samples from influenza-infected and
normal patients was used as a control panel to determine the
background optical density (OD) value for determination of a
cutoff. Each diamond represents a sample from one indepen-
dent patient serum. The detection of sNS1 (closed diamond)
and virus-like particle (VLP) (open diamond) were measured
using (A) Ag-ELISA without dissociation and then (B) with
dissociation by treatment with low pH buffer. All sera samples
were plotted against the line indicating the detection limit by
P/N ratio of 2 based on the average of OD readings from the 18
control sera. The graph shows the average results of three
independent experiments performed in duplicate.
Detection kinetics of Ag-ELISA and RT-PCR 7
+ MODELextracellular compartment is delayed compared with the
release of mature virion.22,23 The possible discrepancy
could be due to the sensitivity of antibodies performing
NS1-ELISA or the nature of different flaviviruses. The level
of the sensitivity of the NS1-ELISA in the study by Chung and
Diamond22 was similar to the level we determined in our
current study; therefore, the different abilities of anti-
bodies in capturing NS1 antigen may not be the reason as
the results were affected in both the study of Chung and
Diamond22 and in this study. Furthermore, the detection of
virion released from the infected cells was confirmed by
both real-time RT-PCR and E-ELISA for parallel comparison.
The pattern of detecting E was similar to that of detecting
viral RNA and infectious viruses from our ex vivo tissue
culture experiments as shown in Figure 2. Using our Ag-Please cite this article in press as: Shen W-F, et al., Improving dengue v
low pH glycine buffer treatment, Journal of Microbiology, Im
j.jmii.2015.05.008ELISA, we demonstrated the presence of both free-
circulating NS1 and E in the serum samples collected from
Day 1 to Day 10, which covers the entire clinical phase of
the disease. Levels of NS1 and E peaked in sera from Day 4
to Day 6, approximately the critical defervescence period
of illness (Day 4e7 post onset of fever). The current study
provides collaborative evidence relating the temporal ki-
netics of viral particle secretion and the detectable level of
E during infection, which has traditionally been measured
by the detection of viral RNA.24e27
The recent commercial utility of a rapid dipstick NS1 test
for dengue diagnosis is hindered by low sensitivity, partic-
ularly in patients with secondary infection, requiring
dengue-specific IgM/IgG antibody detection to increase the
accuracy of diagnosis.28e30 Several studies published pre-
viously suggested that using different dissociation buffers
could efficiently dislodge the antigen from the antigen-
antibody immune complex, thereby increasing detection
sensitivity by up to 35%.12,31 In this study, dissociation of
DENV immune complexes proved essential for the detection
of both DENV E and NS1 in serum samples, particularly
among samples from secondary DENV infections, as evi-
denced by dramatically increased assay detection rates
(85% for NS1-ELISA and 92% for E-ELISA) following dissocia-
tion. The enhanced detection of E might also be the result
of dissociation of immune complexes and hence increased
the accessibility of mAb-specific epitopes. However, the
reduced P/N ratio for the sNS1 after treating with the low-
pH dissociation buffer was noted here (Figure 4) and the
reasons could be the labile NS1 to the acid treatment and
the selection of mAb that recognized conformationally
sensitive epitopes as suggested by a previous study.22 The
results from the current study suggest that the dissociation
of immune complexes may render E-containing viral parti-
cles a valuable target for acute DENV diagnosis, similar to
NS1 detection. Selection of a nonionic detergent for im-
mune complex dissociation to improve the antigen detec-
tion should be the focus for future study.
The limitation of the current study was the small sample
size and relatively long duration of storage of clinical
specimens used. However, these samples were stored in
75C and only the aliquots without previously freeze-
ethawed cycles were used. In a planned future study, the
intention is to increase the sample size of DENV-2 and
expand this protocol to test DENV-1, DENV-3, and DENV-4
patient serum specimens, pretreated specimens with
dissociation buffer, and compare our E- as well as NS1-
ELISA with the available commercial DENV NS1 detection
kits.Conflicts of interest
We declare that we have no conflicts of interest.Acknowledgments
We thank Ya-Huei Shen at the Yuan’s General Hospitals for
kindly providing clinical samples and Nicole Trainor for
English editing. This study was supported by the National
Science Council Taiwan (96-3111-B-005-001- and 98-2320-B-iral antigens detection in dengue patient serum specimens using a
munology and Infection (2015), http://dx.doi.org/10.1016/
8 W.-F. Shen et al.
+ MODEL005-003-MY3). The funders had no role in study design, data
collection and analysis, decision to publish, or preparation
of the manuscript.
References
1. Bhatt S, Gething P, Brady O, Messina J, Farlow A, Moyes C,
et al. The global distribution and burden of dengue. Nature
2013;496:504e7.
2. Lindenbach BD, Rice CM. Flaviviridae: the viruses and their
replication. In: Knipe DM, Howley PM, editors. Fields’ Virology.
4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2001.
p. 991e1110.
3. Mason PW. Maturation of Japanese encephalitis virus glyco-
proteins produced by infected mammalian and mosquito cells.
Virology 1989;169:354e64.
4. Voge N, Sa´nchez-Vargas I, Blair C, Eisen L, Beaty B. Detection
of dengue virus NS1 antigen in infected Aedes aegypti using a
commercially available kit. Am J Trop Med Hyg 2013;88:
260e6.
5. Noisakran S, Dechtawewat T, Avirutnan P, Kinoshita T,
Siripanyaphinyo U, Puttikhunt C, et al. Association of dengue
virus NS1 protein with lipid rafts. J Gen Virol 2008;89:
2492e500.
6. Libraty D, Young P, Pickering D, Endy T, Kalayanarooj S,
Green S, et al. High circulating levels of the dengue virus
nonstructural protein NS1 early in dengue illness correlate with
the development of dengue hemorrhagic fever. J Infect Dis
2002;186:1165e8.
7. Thomas L, Najioullah F, Verlaeten O, Martial J, Brichler S,
Kaidomar S, et al. Relationship between nonstructural protein
1 detection and plasma virus load in dengue patients. Am J
Trop Med Hyg 2010;83:696e9.
8. Arya S, Agarwal N. NS1 detection in addition to reverse tran-
scriptase PCR and transcription-mediated amplification of
dengue virus RNA in acutely ill patients. J Clin Microbiol 2009;
47:1983. http://dx.doi.org/10.1128/JCM.00719-09.
9. Duyen H, Ngoc T, Ha dT, Hang V, Kieu N, Young P, et al. Kinetics
of plasma viremia and soluble nonstructural protein 1 con-
centrations in dengue: differential effects according to sero-
type and immune status. J Infect Dis 2011;203:1292e300.
10. Felix A, Romano C, Centrone Cde C, Rodrigues C, Villas-Boas L,
Arau´jo E, et al. Low sensitivity of NS1 protein tests evidenced
during a dengue type 2 virus outbreak in Santos, Brazil, in 2010.
Clin Vaccine Immunol 2012;19:1972e6.
11. Fry S, Meyer M, Semple M, Simmons C, Sekaran S, Huang J,
et al. The diagnostic sensitivity of dengue rapid test assays is
significantly enhanced by using a combined antigen and anti-
body testing approach. PLoS Negl Trop Dis 2011;5:e1199.
12. Koraka P, Burghoorn-Maas C, Falconar A, Setiati T,
Djamiatun K, Groen J, et al. Detection of immune-complex-
dissociated nonstructural-1 antigen in patients with acute
dengue virus infections. J Clin Microbiol 2003;41:4154e9.
13. Wu HC, Jung MY, Chiu CY, Chao TT, Lai SC, Jan JT, et al.
Identification of a dengue virus type 2 (DEN-2) serotype-
specific B-cell epitope and detection of DEN-2-immunized an-
imal serum samples using an epitope-based peptide antigen. J
Gen Virol 2003;84:2771e9.
14. Chen YC, Huang HN, Lin CT, Chen YF, King CC, Wu HC. Gen-
eration and characterization of monoclonal antibodies against
dengue virus type 1 for epitope mapping and serological
detection by epitope-based peptide antigens. Clin Vaccine
Immunol 2007;14:404e11.
15. Chang GJ, Hunt AR, Davis BS. A single intramuscular injection
of recombinant plasmid DNA induces protective immunity and
prevents Japanese encephalitis in mice. J Virol 2000;74:
4244e52.Please cite this article in press as: Shen W-F, et al., Improving dengue v
low pH glycine buffer treatment, Journal of Microbiology, Im
j.jmii.2015.05.00816. Chang GJ, Hunt AR, Holmes DA, Springfield T, Chiueh T,
Roehrig J, et al. Enhancing biosynthesis and secretion of pre-
membrane and envelope proteins by the chimeric plasmid of
dengue type 2 and Japanese encephalitis virus. Virology 2003;
306:170e80.
17. Davis BS, Chang GJ, Cropp B, Roehrig J, Martin D, Mitchell C,
et al. West Nile virus recombinant DNA vaccine protects mouse
and horse from virus challenge and expresses in vitro a
noninfectious recombinant antigen that can be used in
enzyme-linked immunosorbent assays. J Virol 2001;75:
4040e7.
18. Purdy DE, Noga AJ, Chang GJ. Noninfectious recombinant an-
tigen for detection of St. Louis encephalitis virus-specific an-
tibodies in serum by enzyme-linked immunosorbent assay. J
Clin Microbiol 2004;42:4709e17.
19. Ohtaki N, Takahashi H, Kaneko K, Gomi Y, Ishikawa T, Higashi Y,
et al. Purification and concentration of non-infectious West
Nile virus-like particles and infectious virions using a pseudo-
affinity Cellufine Sulfate column. J Virol Methods 2011;174:
131e5.
20. World Health Organization. Dengue: guidelines for diagnosis,
treatment, prevention and controldnew edition. Geneva:
WHO Press; 2009. p. 91e106.
21. Shu P, Huang J. Current advances in dengue diagnosis. Clin
Diagn Lab Immunol 2004;11:642e50.
22. Chung K, Diamond M. Defining the levels of secreted non-
structural protein NS1 after West Nile virus infection in cell
culture and mice. J Med Virol 2008;80:547e56.
23. Macdonald J, Tonry J, Hall R, Williams B, Palacios G, Ashok M,
et al. NS1 protein secretion during the acute phase of West Nile
virus infection. J Virol 2005;79:13924e33.
24. Vazquez S, Ruiz D, Barrero R, Ramirez R, Calzada N, del
Rosario P, et al. Kinetics of dengue virus NS1 protein in dengue
4-confirmed adult patients. Diagn Microbiol Infect Dis 2010;68:
46e9.
25. Castro-Jorge L, Machado P, Favero C, Borges M, Passos L, de
Oliveira R, et al. Clinical evaluation of the NS1 antigen-capture
ELISA for early diagnosis of dengue virus infection in Brazil. J
Med Virol 2010;82:1400e5.
26. Wang S, Sekaran S. Evaluation of a commercial SD dengue virus
NS1 antigen capture enzyme-linked immunosorbent assay kit
for early diagnosis of dengue virus infection. J Clin Microbiol
2010;48:2793e7.
27. Huhtamo E, Hasu E, Uzcategui N, Erra E, Nikkari S, Kantele A,
et al. Early diagnosis of dengue in travelers: comparison of a
novel real-time RT-PCR, NS1 antigen detection and serology. J
Clin Virol 2010;47:49e53.
28. Chaterji S, Allen Jr JC, Chow A, Leo Y-S, Ooi E-E. Evaluation of
the NS1 rapid test and the WHO dengue classification schemes
for use as bedside diagnosis of acute dengue fever in adults.
Am J Trop Med Hyg 2011;84:224e8.
29. Tricou V, Vu HT, Quynh NV, Nguyen C, Tran H, Farrar J, et al.
Comparison of two dengue NS1 rapid tests for sensitivity,
specificity and relationship to viraemia and antibody re-
sponses. BMC Infect Dis 2010;10:142. http:
//dx.doi.org/10.1186/1471-2334-10-142.
30. Blacksell S, Jarman R, Bailey M, Tanganuchitcharnchai A,
Jenjaroen K, Gibbons R, et al. Evaluation of six commercial
point-of-care tests for diagnosis of acute dengue infections:
the need for combining NS1 antigen and IgM/IgG antibody
detection to achieve acceptable levels of accuracy. Clin Vac-
cine Immunol 2011;18:2095e101.
31. Li C, Jaentschke B, Song Y, Wang J, Cyr T, Van Domselaar G,
et al. A simple slot blot for the detection of virtually all sub-
types of the influenza A viral hemagglutinins using universal
antibodies targeting the fusion peptide. Nat Protoc 2010;5:
14e9.iral antigens detection in dengue patient serum specimens using a
munology and Infection (2015), http://dx.doi.org/10.1016/
